Official: China prepares for mass vaccine production

Research and development of novel coronavirus vaccines in China is nearing its conclusion, while preparations are in place for their mass production, said the head of China's COVID-19 vaccine development task force.

There are five domestically developed vaccines undergoing phase-3 clinical trials, the final stage of trials before attaining approval from authorities, making China a leading country in global COVID-19 vaccine development, said Zheng Zhongwei, who is also director of the National Health Commission's Development Center for Medical Science and Technology.

Despite taking a leading role in COVID-19 vaccine research and development, China is not rushing to compete with other countries in this field, Zheng told Xinhua News Agency.